Top

Published in:

01-08-2020 | Autism Spectrum Disorder | Review

Perinatal Inflammation Reprograms Neuroendocrine, Immune, and Reproductive Functions: Profile of Cytokine Biomarkers

Authors: Marina Izvolskaia, Viktoriya Sharova, Liudmila Zakharova

Published in: Inflammation | Issue 4/2020

Abstract

Viral and bacterial infections causing systemic inflammation are significant risk factors for developing body. Inflammatory processes can alter physiological levels of regulatory factors and interfere with developmental mechanisms. The brain is the main target for the negative impact of inflammatory products during critical ontogenetic periods. Subsequently, the risks of various neuropsychiatric diseases such as Alzheimer’s and Parkinson’s diseases, schizophrenia, and depression are increased in the offspring. Inflammation-induced physiological disturbances can cause immune and behavioral disorders, reproductive deficiencies, and infertility. The influence of maternal immune stress is mediated by the regulation of pro-inflammatory cytokines such as interleukin (IL)-1β, IL-6, monocyte chemotactic protein 1, leukemia-inhibiting factor, and tumor necrosis factor-alpha secretion in the maternal-fetal system. The increasing number of patients with neuronal and reproductive disorders substantiates the identification of biomarkers for these disorders targeted at their therapy.

Zakharova, L.A. 2009. Plasticity of neuroendocrine-immune interactions during ontogeny: Role of perinatal programming in pathogenesis of inflammation and stress-related diseases in adults. Recent Patents on Endocrine, Metabolic & Immune Drug Discovery 3: 11–27.CrossRef

Zakharova, L.A., Izvolskaia, M.S. 2012. Interactions between the reproductive and immune systems during ontogenesis: The role of GnRH, sex steroids and immunomediators. In Sex steroids Kahn SM editor Zagreb InTech 341–370.

Zakharova, L. 2015. Perinatal stress in brain programming and pathogenesis of psychoneurological disorders. The Biological Bulletin 42: 12–20. https://doi.org/10.1134/S1062359015010124.CrossRef

Izvolskaia, M., V. Sharova, and L. Zakharova. 2018. Prenatal programming of neuroendocrine system development by lipopolysaccharide: Long-term effects. International Journal of Molecular Sciences 19: E 3695. https://doi.org/10.3390/ijms19113695.CrossRef

Ardalan, M., T. Chumak, Z. Vexler, and C. Mallard. 2019. Sex-dependent effects of perinatal inflammation on the brain: Implication for neuro-psychiatric disorders. International Journal of Molecular Sciences 20 (9): E2270. https://doi.org/10.3390/ijms20092270.CrossRefPubMed

Saghazadeh, A., B. Ataeinia, K. Keynejad, A. Abdolalizadeh, A. Hirbod-Mobarakeh, and N.A. Rezaei. 2019. Meta-analysis of pro-inflammatory cytokines in autism spectrum disorders: Effects of age, gender, and latitude. Journal of Psychiatric Research 115: 90–102. https://doi.org/10.1016/j.jpsychires.2019.05.019.CrossRefPubMed

Hagberg, H., P. Gressens, and C. Mallard. 2012. Inflammation during fetal and neonatal life: Implications for neurologic and neuropsychiatric disease in children and adults. Annals of Neurology 71: 444–457. https://doi.org/10.1038/nrneurol.2015.13.CrossRefPubMed

Lucchina, L., and A.M. Depino. 2014. Altered peripheral and central inflammatory responses in a mouse model of autism. Autism Research 7: 273–289. https://doi.org/10.1002/aur.1338.CrossRefPubMed

Gilstrap, L.C., 3rd, and S.M. Ramin. 2001. Urinary tract infections during pregnancy. Obstetrics and Gynecology Clinics of North America 28: 581–591. https://doi.org/10.1016/s0889-8545(05)70219-9.CrossRefPubMed

10.

Cui, K., H. Ashdown, G.N. Luheshi, and P. Boksa. 2009. Effects of prenatal immune activation on hippocampal neurogenesis in the rat. Schizophrenia Research 113: 288–297. https://doi.org/10.1016/j.schres.2009.05.003.CrossRefPubMed

11.

Wang, S., J.Y. Yan, Y.K. Lo, P.M. Carvey, and Z. Ling. 2009. Dopaminergic and serotoninergic deficiencies in young adult rats prenatally exposed to the bacterial lipopolysaccaharide. Brain Research 1265: 196–204. https://doi.org/10.1016/j.brainres.2009.02.022.CrossRefPubMed

12.

Vivekanantham, S., S. Shah, R. Dewji, A. Dewji, C. Khatri, and R. Ologunde. 2015. Neuroinflammation in Parkinson’s disease: Role in neurodegeneration and tissue repair. The International Journal of Neuroscience 125: 717–725. https://doi.org/10.3109/00207454.2014.982795.CrossRefPubMed

13.

Clark, L.F., and T. Kodadek. 2016. The immune system and neuroinflammation as potential sources of blood-based biomarkers for Alzheimer’s disease, Parkinson’s disease, and Huntington’s disease. ACS Chemical Neuroscience 7: 520–527. https://doi.org/10.1021/acschemneuro.6b00042.CrossRefPubMed

14.

Sharova, V.S., M.S. Izvolskaia, and L.A. Zakharova. 2015. Lipopolysaccharide-induced maternal inflammation affects the gonadotropin-releasing hormone neuron development in fetal mice. Neuroimmunomodulation 22 (4): 222–232. https://doi.org/10.1159/000365482.CrossRefPubMed

15.

Ignatiuk, V.M., M.S. Izvolskaya, V.S. Sharova, S.N. Voronova, and L.A. Zakharova. 2019. Disruptions in the reproductive system of female rats after prenatal lipopolysaccharide-induced immunological stress: Role of sex steroids. Stress 21 (5): 1–9. https://doi.org/10.1080/10253890.2018.1508440.CrossRef

16.

Lei, L., S. Jin, K.E. Mayo, and T.K. Woodruff. 2010. The interactions between the stimulatory effect of follicle-stimulating hormone and the inhibitory effect of estrogen on mouse primordial folliculogenesis. Biology of Reproduction 82 (1): 13–22. https://doi.org/10.1095/biolreprod.109.077404.CrossRefPubMed

17.

Carvey, P.M., Q. Chang, J.W. Lipton, and Z. Ling. 2003. Prenatal exposure to the bacteriotoxin lipopolysaccharide leads to long-term losses of dopamine neurons in offspring: A potential, new model of Parkinson’s disease. Frontiers in Bioscience 8: s826–s837. https://doi.org/10.2741/1158.CrossRefPubMed

18.

American Psychiatric Association, ed. 2013. Diagnostic and statistical manual of mental disorders, fifth edition (DSM-5). 5th ed. Arlington: American Psychiatric Association.

19.

Hazlett, H.C., M. Poe, G. Gerig, М. Styner, С. Chappell, R.G. Smith, C. Vachet, and J. Piven. 2011. Early brain overgrowth in autism associated with an increase in cortical surface area before age 2 years. Archives of General Psychiatry 68: 467–476. https://doi.org/10.1001/archgenpsychiatry.2011.39.CrossRefPubMedPubMedCentral

20.

Mannion, A., G. Leader, and O. Healy. 2013. An investigation of comorbid psychological disorders, sleep problems, gastrointestinal symptoms and epilepsy in children and adolescents with autism spectrum disorder. Research in Autism Spectrum Disorder 7: 35–42.CrossRef

21.

Beard, C.M., L.A. Panser, and S.K. Katusic. 2011. Is excess folic acid supplementation a risk factor for autism? Medical Hypotheses 77: 15–17. https://doi.org/10.1016/j.mehy.2011.03.013.CrossRefPubMed

22.

Zhou, S.S., Y.M. Zhou, D. Li, and Q. Ma. 2013. Early infant exposure to excess multivitamin: A risk factor for autism? Autism Research and Treatment 963697. https://doi.org/10.1155/2013/963697.

23.

Nicolson, G.L., R. Gan, N.L. Nicolson, and J. Haier. 2007. Evidence for Mycoplasma ssp., Chlamydia pneunomiae, and human herpesvirus-6 coinfections in the blood of patients with autistic spectrum disorders. Journal of Neuroscience Research 85: 1143–1148. https://doi.org/10.1002/jnr.21203.CrossRefPubMed

24.

Patterson, P.H. 2011. Maternal infection and immune involvement in autism. Trends in Molecular Medicine 17: 389–394. https://doi.org/10.1016/j.molmed.2011.03.001.CrossRefPubMedPubMedCentral

25.

Atladóttir, H.Ó., T.B. Henriksen, D.E. Schendel, and E.T. Parner. 2012. Autism after infection, febrile episodes, and antibiotic use during pregnancy: An exploratory study. Pediatrics 130: e1447–e1454. https://doi.org/10.1542/peds.2012-1107.CrossRefPubMedPubMedCentral

26.

Melnikova, V.I., M.A. Afanasyeva, S.N. Voronova, and L.A. Zakharova. 2012. The effect of catecholamine deficit on the development of the immune system in rats. Doklady Biological Sciences 443: 68–70. https://doi.org/10.1134/S001249661202007X.CrossRefPubMed

27.

Lifantseva, N.V., T.O. Koneeva, S.N. Voronova, L.A. Zakharova, and V.I. Melnikova. 2016. The inhibition of dopamine synthesis in fetuses changes the pattern of T-lymphocyte maturation in the thymus of adult rats. Doklady. Biochemistry and Biophysics 470 (1): 342–344. https://doi.org/10.1134/S1607672916050082.CrossRefPubMed

28.

Chaste, P., and M. Leboyer. 2012. Autism risk factors: Genes, environment, and gene-environment interactions. Dialogues in Clinical Neuroscience 14: 281–292.PubMedPubMedCentral

29.

Onore, C., M. Careaga, and P. Ashwood. 2012. The role of immune dysfunction in the pathophysiology of autism. Brain, Behavior, and Immunity 26 (3): 383–392. https://doi.org/10.1016/j.bbi.2011.08.007.CrossRefPubMed

30.

Rose, D., and P. Ashwood. 2014. Potential cytokine biomarkers in autism spectrum disorders. Biomarkers in Medicine 8 (9): 1171–1181. https://doi.org/10.2217/bmm.14.39.CrossRefPubMed

31.

Mead, J., and P. Ashwood. 2015. Evidence supporting an altered immune response in ASD. Immunology Letters 163: 49–55. https://doi.org/10.1016/j.imlet.2014.11.006.CrossRefPubMed

32.

Krakowiak, P., P.E. Goines, D.J. Tancredid, P. Ashwoodc, R.L. Hansenc, I. Hertz-Picciottoa, and J. Van de Waterb. 2017. Neonatal cytokine profiles associated with autism spectrum disorder. Biological Psychiatry 81: 442–451. https://doi.org/10.1016/j.biopsych.2015.08.007.CrossRefPubMed

33.

Atladóttir, H.Ó., P. Thorsen, D.E. Schendel, L. Østergaard, S. Lemcke, and E.T. Parner. 2010. Association of hospitalization for infection in childhood with diagnosis of autism spectrum disorders. Archives of Pediatrics & Adolescent Medicine 164: 470–477. https://doi.org/10.1001/archpediatrics.2010.9.CrossRef

34.

Gottfried, C., V. Bambini-Junior, F. Francis, R. Riesgo, and W. Savino. 2015. The impact of neuroimmune alterations in autism spectrum disorder. Frontiers in Psychiatry 6: 121. https://doi.org/10.3389/fpsyt.2015.00121.CrossRefPubMedPubMedCentral

35.

Vargas, D.L., C. Nascimbene, C. Krishnan, A.W. Zimmerman, and C.A. Pardo. 2005. Neuroglial activation and neuroinflammation in the brain of patients with autism. Annals of Neurology 57: 67–81. https://doi.org/10.1002/ana.20315.CrossRefPubMed

36.

Masi, A., E.J. Breen, G.A. Alvares, N. Glozier, I.B. Hickie, A. Hunt, J. Hui, J. Beilby, D. Ravine, J. Wray, A.J.O. Whitehouse, and J. Adam. 2017. Guastella cytokine levels and associations with symptom severity in male and female children with autism spectrum disorder. Molecular Autism 8: 63. https://doi.org/10.1186/s13229-017-0176-2.CrossRefPubMedPubMedCentral

37.

Autism and Developmental Disabilities Monitoring Network Surveillance Year. 2008. Principal investigators, prevalence of autism spectrum disorders–Autism and developmental disabilities monitoring network, 14 sites, United States. MMWR Surveillance Summaries 61 (3): 1–19 https://www.cdc.gov/MMWR/PREVIEW/MMWRHTML/SS6103A1.HTM. Accessed 30 March 2012.

38.

Werling, D.M., N.N. Parikshak, and D.H. Geschwind. 2016. Gene expression in human brain implicates sexually dimorphic pathways in autism spectrum disorders. Nature Communications 7: 0717. https://doi.org/10.1038/ncomms10717.CrossRef

39.

Harro, M., D. Eensoo, and E. Kiiveetal. 2001. Platelet monoamineoxidase in healthy 9-and 15-years old children: The effect of gender, smoking and puberty. Progress in Neuro-Psychopharmacology and Biological Psychiatry 25: 1497–1511. https://doi.org/10.1016/s0278-5846(01)00212-3.CrossRefPubMed

40.

Ahmad, S.F., A. Nadeem, M.A. Ansari, S.A. Bakheet, L.Y. Al-Ayadhi, and S.M. Attia. 2017. Upregulation of IL-9 and JAK-STAT signaling pathway in children with autism. Progress in Neuro-Psychopharmacology & Biological Psychiatry 79 (Pt B): 472–480. https://doi.org/10.1016/j.pnpbp.2017.08.002.CrossRef

41.

Bransfield, R.C., J.S. Wulfman, W.T. Harvey, and A.I. Usman. 2008. The association between tick-borne infections, Lyme borreliosis and autism spectrum disorders. Medical Hypotheses 70: 967–974. https://doi.org/10.1016/j.mehy.2007.09.006.CrossRefPubMed

42.

Abib, R.T., A. Gaman, A.A. Dargél, R. Tamouza, F. Kapczinski, C. Gottfried, and M. Leboyer. 2018. Intracellular pathogen infections and immune response in autism. Neuroimmunomodulation 25 (5–6): 271–279. https://doi.org/10.1159/000491821.CrossRefPubMed

43.

Jyonouchi, H., L. Geng, and A.L. Davidow. 2014. Cytokine profiles by peripheral blood monocytes are associated with changes in behavioral symptoms following immune insults in a subset of ASD subjects: An inflammatory subtype? Journal of Neuroinflammation 11: 187. https://doi.org/10.1186/s12974-014-0187-2.CrossRefPubMedPubMedCentral

44.

Beurel, E., and R.S. Jope. 2009. Lipopolysaccharide-induced interleukin-6 production is controlled by glycogen synthase kinase-3 and STAT3 in the brain. Journal of Neuroinflammation 6: 9. https://doi.org/10.1186/1742-2094-6-9.CrossRefPubMedPubMedCentral

45.

Martin, M., K. Rehani, R.S. Jope, and S.M. Michalek. 2005. Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nature Immunology 6: 777–784. https://doi.org/10.1038/ni1221.CrossRefPubMedPubMedCentral

46.

Liu, J.T., B.Y. Chen, J.Q. Zhang, F. Kuang, and L.W. Chen. 2015. Lead exposure induced microgliosis and astrogliosis in hippocampus of young mice potentially by triggering TLR4-MyD88-NFκB signaling cascades. Toxicology Letters 239 (2): 97–107. https://doi.org/10.1016/j.toxlet.2015.09.015.CrossRefPubMed

47.

Holmlund, U., G. Cebers, and A.R. Dahlfors. 2002. Expression and regulation of the pattern recognition receptors toll-like receptor-2 and toll-like receptor-4 in the human placenta. Immunology 107 (1): 145–151. https://doi.org/10.1046/j.1365-2567.2002.01491.x.CrossRefPubMedPubMedCentral

48.

Beijar, E.C., C. Mallard, and T.L. Powell. 2006. Expression and subcellular localization of TLR-4 in term and first trimester human placenta. Placenta 27 (2–3): 322–326. https://doi.org/10.1016/j.placenta.2004.12.012.CrossRefPubMed

49.

Lye, P., E. Bloise, M. Javam, W. Gibb, S.J. Lye, and S.G. Matthews. 2015. Impact of bacterial and viral challenge on multidrug resistance in first- and third-trimester human placenta. The American Journal of Pathology 185 (6): 1666–1675. https://doi.org/10.1016/j.ajpath.2015.02.013.CrossRefPubMed

50.

Kirsten, T.B., and M.M. Bernardi. 2017. Prenatal lipopolysaccharide induces hypothalamic dopaminergic hypoactivity and autistic-like behaviors: Repetitive self-grooming and stereotypies. Behavioural Brain Research 331: 25–29. https://doi.org/10.1016/j.bbr.2017.05.013.CrossRefPubMed

51.

Custódio, C.S., B.S.F. Mello, A.J.M.C. Filho, C.N. de Carvalho Lima, R.C. Cordeiro, and F. Miyajima. 2018. Neonatal immune challenge with lipopolysaccharide triggers long-lasting sex- and age-related behavioral and immune/Neurotrophic alterations in mice: Relevance to autism Spectrum disorders. Molecular Neurobiology 55 (5): 3775–3788. https://doi.org/10.1007/s12035-017-0616-1.CrossRefPubMed

52.

Foley, K.A., D.F. MacFabe, M. Kavaliers, and K.P. Ossenkopp. 2015. Sexually dimorphic effects of prenatal exposure to lipopolysaccharide, and prenatal and postnatal exposure to propionic acid, on acoustic startle response and prepulse inhibition in adolescent rats: Relevance to autism spectrum disorders. Behavioural Brain Research 278: 244–225. https://doi.org/10.1007/s12035-017-0616-1.CrossRefPubMed

53.

Pradhan, S., and K. Andreasson. 2013. Commentary: Progressive inflammation as a contributing factor to early development of Parkinson’s disease. Experimental Neurology 241: 148–155. https://doi.org/10.1016/j.expneurol.2012.12.008.CrossRefPubMed

54.

Choi, I., D.J. Choi, H. Yang, J.H. Woo, M.Y. Chang, J.Y. Kim, W. Sun, S.M. Park, I. Jou, S.H. Lee, and E.H. Joe. 2016. PINK1 expression increases during brain development and stem cell differentiation, and affects the development of GFAP-positive astrocytes. Molecular Brain 9: 5. https://doi.org/10.1186/s13041-016-0186-6.CrossRefPubMedPubMedCentral

55.

Alexander, G.E. 2004. Biology of Parkinson’s disease: Pathogenesis and pathophysiology of a multisystem neurodegenerative disorder. Dialogues in Clinical Neuroscience 6: 259–280.PubMedPubMedCentral

56.

Lotankar, S., K.S. Prabhavalkar, and L.K. Bhatt. 2017. Biomarkers for Parkinson’s disease: Recent advancement. Neuroscience Bulletin 33 (5): 585–597. https://doi.org/10.1007/s12264-017-0183-5.CrossRefPubMedPubMedCentral

57.

De Virgilio, A., A. Greco, G. Fabbrini, M. Inghilleri, M.I. Rizzom, A. Gallo, M. Conte, C. Rosato, M. Ciniglio Appiani, and M. de Vincentiis. 2016. Parkinson’s disease: Autoimmunity and neuroinflammation. Autoimmunity Reviews 15 (10): 1005–1011. https://doi.org/10.1016/j.autrev.2016.07.022.CrossRefPubMed

58.

Konno, T., J. Siuda, and Z.K. Wszolek. 2016. Genetics of Parkinson’s disease: A review of SNCA and LRRK2. Wiadomości Lekarskie 69: 328–332.PubMed

59.

Calne, D.B., and J.W. Langston. 1983. Aetiology of Parkinson’s disease. Lancet 2 (8365–8366): 1457–1459.CrossRef

60.

Ling, Z.D., Q. Chang, J.W. Lipton, C.W. Tong, T.M. Landers, and P.M. Carvey. 2004. Combined toxicity of prenatal bacterial endotoxin exposure and postnatal 6-hydroxydopamine in the adult rat midbrain. Neuroscience 124: 619–628. https://doi.org/10.1016/j.neuroscience.2003.12.017.CrossRefPubMed

61.

Ling, Z., Q.A. Chang, C.W. Tong, S.E. Leurgans, J.W. Lipton, and P.M. Carvey. 2004. Rotenone potentiates dopamine neuron loss in animals exposed to lipopolysaccharide prenatally. Experimental Neurology 190: 373–383. https://doi.org/10.1016/j.expneurol.2004.08.006.CrossRefPubMed

62.

Richardson, J.R., W.M. Caudle, M. Wang, E.D. Dean, K.D. Pennell, and G.W. Miller. 2006. Developmental exposure to the pesticide dieldrin alters the dopamine system and increases neurotoxicity in an animal model of Parkinson’s disease. The FASEB Journal 20: 1695–1697. https://doi.org/10.1096/fj.06-5864fje.CrossRefPubMed

63.

Lloyd, S.A., C.J. Faherty, and R.J. Smeyne. 2006. Adult and in utero exposure to cocaine alters sensitivity to the Parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neuroscience 137: 905–913. https://doi.org/10.1016/j.neuroscience.2005.09.035.CrossRefPubMed

64.

Machado, V., S.J. Haas, O. von Bohlen Und Halbach, A. Wree, K. Krieglstein, K. Unsicker, and B. Spittau. 2016. Growth/differentiation factor-15 deficiency compromises dopaminergic neuron survival and microglial response in the 6-hydroxydopamine mouse model of Parkinson’s disease. Neurobiology of Disease 88: 1–15. https://doi.org/10.1016/j.nbd.2015.12.016.CrossRefPubMed

65.

Chen, S., Y. Liu, Y. Niu, Y. Xu, Q. Zhou, X. Xu, J. Wang, and M. Yu. 2017. Increased abundance of myeloid-derived suppressor cells and Th17 cells in peripheral blood of newly-diagnosed Parkinson’s disease patients. Neuroscience Letters 648: 21–25. https://doi.org/10.1016/j.neulet.2017.03.045.CrossRefPubMed

66.

Sommer, A., B. Winner, and I. Prots. 2017. The Trojan horse-neuroinflammatory impact of T cells in neurodegenerative diseases. Molecular Neurodegeneration 12 (1): 78. https://doi.org/10.1186/s13024-017-0222-8.CrossRefPubMedPubMedCentral

67.

Rathnayake, D., T. Chang, and P. Udagama. 2019. Selected serum cytokines and nitric oxide as potential multi-marker biosignature panels for Parkinson disease of varying durations: A case-control study. BMC Neurology 19: 56. https://doi.org/10.1186/s12883-019-1286-6.CrossRefPubMedPubMedCentral

68.

Kim, R., H.J. Kim, A. Kim, M. Jang, A. Kim, Y. Kim, D. Yoo, J.H. Im, J.H. Choi, and B. Jeon. 2018. Peripheral blood inflammatory markers in early Parkinson’s disease. Journal of Clinical Neuroscience 58: 30–33. https://doi.org/10.1016/j.jocn.2018.10.079.CrossRefPubMed

69.

Ling, Z., D.A. Gayle, S.Y. Ma, J.W. Lipton, C.W. Tong, J.S. Hong, and P.M. Carvey. 2002. In utero bacterial endotoxin exposure causes loss of tyrosine hydroxylase neurons in the postnatal rat midbrain. Movement Disorders 17 (1): 116–124. https://doi.org/10.1002/mds.10078.CrossRefPubMed

70.

Ling, Z., Y. Zhu, C.W. Tong, J.A. Snyder, J.W. Lipton, and P.M. Carvey. 2009. Prenatal lipopolysaccharide does not accelerate progressive dopamine neuron loss in the rat as a result of normal aging. Experimental Neurology 216: 312–320. https://doi.org/10.1016/j.expneurol.2008.12.004.CrossRefPubMed

71.

Bernardi, M.M., T.B. Kirsten, S.M. Matsuoka, E. Teodorov, S.F. Habr, S.H. Penteado, and J. Palermo-Neto. 2010. Prenatal lipopolysaccharide exposure affects maternal behavior and male offspring sexual behavior in adulthood. Neuroimmunomodulation 17: 47–55. https://doi.org/10.1159/000243085.CrossRefPubMed

72.

Solati, J., R. Hajikhani, B. Rashidieh, and M.F. Jalilian. 2012. Effects of prenatal lipopolysaccharide exposure on reproductive activities and serum concentrations of pituitary-gonadal hormones in mice offspring. International Journal of Fertility and Sterility 6: 51–58.PubMed

73.

Wang, H., L.L. Yang, Y.F. Hu, B.W. Wang, Y.Y. Huang, C. Zhang, Y.H. Chen, and D.X. Xu. 2014. Maternal LPS exposure during pregnancy impairs testicular development, steroidogenesis and spermatogenesis in male offspring. PLoS One 9 (9). https://doi.org/10.1371/journal.pone.0106786.

74.

Ashdown, H., Y. Dumont, M. Ng, S. Poole, P. Boksa, and G.N. Luheshi. 2006. The role of cytokines in mediating effects of prenatal infection on the fetus: Implications for schizophrenia. Molecular Psychiatry 11: 47–55. https://doi.org/10.1038/sj.mp.4001748.CrossRefPubMed

75.

Liverman, C.S., H.A. Kaftan, L. Cui, S.G. Hersperger, E. Taboada, R.M. Klein, and N.E. Berman. 2006. Altered expression of pro-inflammatory and developmental genes in the fetal brain in a mouse model of maternal infection. Neuroscience Letters 399 (3): 220–225. https://doi.org/10.1016/j.neulet.2006.01.064.CrossRefPubMed

76.

Bornstein, S.R., H. Rutkowski, and I. Vrezas. 2004. Cytokines and steroidogenesis. Molecular and Cellular Endocrinology 215 (1–2): 135–141. https://doi.org/10.1016/j.mce.2003.11.022.CrossRefPubMed

77.

Skinner, M.K. 2005. Regulation of primordial follicle assembly and development. Human Reproduction Update 11 (5): 461–471. https://doi.org/10.1093/humupd/dmi020.CrossRefPubMed

78.

Cheng, L., D.P. Gearing, L.S. White, D.L. Compton, K. Schooley, and P.J. Donovan. 1994. Role of leukemia inhibitory factor and its receptor in mouse primordial germ cell growth. Development 120 (11): 3145–3153.PubMed

79.

Eddie, S.L., A.J. Childs, H.N. Jabbour, and R.A. Anderson. 2012. Developmentally regulated IL6-type cytokines signal to germ cells in the human fetal ovary. Molecular Human Reproduction 18: 88–95. https://doi.org/10.1093/molehr/gar061.CrossRefPubMed

80.

Izvolskaia, M.S., V.S. Sharova, V.M. Ignatiuk, S.N. Voronova, and L.A. Zakharova. 2019. Abolition of prenatal lipopolysaccharide-induced reproductive disorders in rat male offspring by fulvestrant. Andrologia 51: e13204. https://doi.org/10.1111/and.13204.CrossRefPubMed

81.

Williams, K., C. McKinnell, P.T. Saunders, M. Walker, J.S. Fisher, K.J. Turner, N. Atanassova, and M. Sharpe. 2001. Neonatal exposure to potent and environmental oestrogens and abnormalities of the male reproductive system in the rat: Evidence for importance of the androgen-oestrogen balance and assessment of the relevance to man. Human Reproduction Update 7: 236–247. https://doi.org/10.1677/JOE-09-0109.CrossRefPubMed

82.

Chen, Y., K. Breen, and M.E. Pepling. 2009. Estrogen can signal through multiple pathways to regulate oocyte cyst breakdown and primordial follicle assembly in the neonatal mouse ovary. The Journal of Endocrinology 202 (3): 407–417. https://doi.org/10.1677/JOE-09-0109.CrossRefPubMed

83.

Talmor, A., and B. Dunphy. 2015. Female obesity and infertility. Best Practice & Research. Clinical Obstetrics & Gynaecology 29 (4): 498–506. https://doi.org/10.1016/j.bpobgyn.2014.10.014.CrossRef

Title: Perinatal Inflammation Reprograms Neuroendocrine, Immune, and Reproductive Functions: Profile of Cytokine Biomarkers
Authors: Marina Izvolskaia
Viktoriya Sharova
Liudmila Zakharova
Publication date: 01-08-2020
Publisher: Springer US
Keywords: Autism Spectrum Disorder
Parkinson's Disease
Cytokines
Biomarkers
Published in: Inflammation / Issue 4/2020
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI: https://doi.org/10.1007/s10753-020-01220-1

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2020

The Fibroblast-Like Synoviocyte Derived Exosomal Long Non-coding RNA H19 Alleviates Osteoarthritis Progression Through the miR-106b-5p/TIMP2 Axis

N-Acetylcysteine Attenuates Lipopolysaccharide-Induced Osteolysis by Restoring Bone Remodeling Balance via Reduction of Reactive Oxygen Species Formation During Osteoclastogenesis

Interferon Regulatory Factor-2 Binding Protein 2 Ameliorates Sepsis-Induced Cardiomyopathy via AMPK-Mediated Anti-Inflammation and Anti-Apoptosis

Foxc2 Alleviates Ox-LDL-Induced Lipid Accumulation, Inflammation, and Apoptosis of Macrophage via Regulating the Expression of Angptl2

Downregulation of lncRNA TUG1 attenuates inflammation and apoptosis of renal tubular epithelial cell induced by ischemia-reperfusion by sponging miR-449b-5p via targeting HMGB1 and MMP2

Glycitin Suppresses Cartilage Destruction of Osteoarthritis in Mice

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage